Pyrazinamide is a first-line anti-tuberculosis medication. Clinically, it is used in combination therapy to target Mycobacterium tuberculosis during the initial intensive phase, and it acts as a bacteriostatic agent that disrupts bacterial protein synthesis and energy metabolism. The term denotes the chemical class and drug name, with pronunciation distinct from its chemical roots rather than everyday usage.
Full pronunciation guide
